Document is current

Article History

Received: 6 October 2021

Accepted: 5 April 2022

First Online: 15 April 2022

Declarations

:

: The CoRIS cohort was approved by the Research Ethic Committee of the Gregorio Marañón Hospital and the study was approved by the Research Ethic Committee of the “12 de Octubre” Hospital (Number 14/080). All the patients signed informed consent to participate in the CoRIS cohort.

: Not applicable.

: MR has received a grant from Gilead Science. IJ has received teaching fees from Viiv and advisory fees from Gilead Science. SM has been involved in speaking activities and has received grants for research from Gilead, Janssen Cilag, Merck Sharp&Dohme, and ViiV Healthcare. RR reports personal fees from ViiV Healthcare and Merck Sharp & Dohme; grants and personal fees from Gilead Sciences and Janssen Cilag. OB reports payments for lectures by Gilead Sciences and ViiV Healthcare, and non-financial support for national conference and national HIV courses from ViiV Healthcare and Merck Sharp and Dohme, outside the submitted work. LD has received honoraria for lectures by Gilead Sciences and ViiV Healthcare, and non-financial support for HIV conferences and courses from Gilead, ViiV Healthcare and Merck Sharp and Dohme, outside the submitted work. All other authors declare that they have no conflict of interest related to this work.